- Report
- October 2024
- 184 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- April 2025
- 283 Pages
Global
From €5249EUR$5,850USD£4,518GBP
- Report
- March 2025
- 146 Pages
Global
From €2691EUR$2,999USD£2,316GBP
- Report
- August 2024
- 178 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- May 2024
- 100 Pages
Africa
From €1795EUR$2,000USD£1,545GBP
- Report
- May 2024
- 80 Pages
United States
From €1346EUR$1,500USD£1,158GBP
- Report
- February 2024
- 180 Pages
Global
From €4459EUR$4,969USD£3,837GBP
- Report
- August 2023
- 113 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- May 2024
- 80 Pages
Argentina
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Brazil
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
China
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
France
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Germany
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
India
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Ireland
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Japan
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Poland
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Russia
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
South Korea
From €1346EUR$1,500USD£1,158GBP

Pyrazinamide is a drug used to treat respiratory diseases, such as tuberculosis. It is a prodrug, meaning it is converted to an active form in the body. It is usually used in combination with other drugs, such as isoniazid and rifampicin, to treat tuberculosis. Pyrazinamide is also used to treat other respiratory diseases, such as Mycobacterium avium complex (MAC) and Mycobacterium kansasii.
Pyrazinamide is available in both oral and injectable forms. It is generally well tolerated, with few side effects. However, it can cause liver damage in some patients, so it is important to monitor liver function when taking this drug.
The pyrazinamide market is a growing one, with many companies offering products. Some of these companies include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more